Interferons in relapsing remitting multiple sclerosis

Lancet. 2003 May 24;361(9371):1825. doi: 10.1016/S0140-6736(03)13423-X.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glatiramer Acetate
  • Humans
  • Interferon beta-1a
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Patient Compliance
  • Patient Satisfaction
  • Peptides / therapeutic use
  • Randomized Controlled Trials as Topic / methods*
  • Research Design
  • Treatment Outcome

Substances

  • Peptides
  • Glatiramer Acetate
  • Interferon-beta
  • Interferon beta-1a